ENTRESTO: NEW DRUG FOR HEART FAILURE

A recent large study has shown that the new drug Entresto has a very positive effect on patients with heart failure: patients are able to live longer and are less often hospitalized due to heart failure. This is probably a medical progression in the treatment of chronic heart failure. (more…)
More

CARDIAC GENE THERAPY IN DEVELOPMENT

Gene therapy for the treatment of chronic heart failure ** A promising gene therapy will soon be tested in trials in the United States on persons. NanoCor Therapeutics has developed an experimental treatment called “Carfostin”: it has recently been accepted as experimental drug. (more…)
More

PLN & EMBRYO SELECTION?

Embryo selection or PIGD, “Pre-Implantation Genetic Diagnosis”, is a difficult ethical issue for PLN gene carriers. Your girlfriend, wife or partner becomes pregnant or wants to become pregnant but one of you has the PLN gene mutation… would you consider such a PIGD procedure  (more…)
More

3D HEART PATCH

In 2014, approximately 26 million people worldwide were living with heart failure. Their heart no longer has the strength to properly pump blood around. Often because a part of the myocardial tissue has died following a heart attack. (more…)
More

ORGAN TRANSPLANT

Made partially possible by the PLN Foundation, a worldwide joint venture has been started under the leadership of the UMCU (the Netherlands) and the university of Pennsylvania (USA) in order to improve the outcomes of organ transplants. (more…)
More

LITSA KRANIAS: THE PLN DISCOVERER

After a visit of the PLN Foundation to the Mount Sinai hospital in New York City, the contact was made with Litsa Kranias. Dr. Kranias is the discoverer and the “mother” of the PLN disorder, and has been playing a very important role for many years already in the Phospholamban studies. (more…)
More